Literature DB >> 25572746

Subclinical carotid atherosclerosis in elderly patients with primary Sjögren syndrome: a duplex Doppler sonographic study.

E M Zardi1, G Sambataro1, F Basta1, D P E Margiotta1, A M V Afeltra1.   

Abstract

A growing body of evidence presents a link between chronic inflammatory rheumatic diseases and atherosclerosis. To evaluate subclinical carotid atherosclerosis in an elderly group of patients with primary Sjögren syndrome compared with a control group matched for age, sex, ethnicity and cardiovascular risk factors, we enrolled 18 patients with Primary Sjögren Syndrome (mean age 65 ± 5.93 SD) and 18 mild Ostheoarthritic patients (mean age 66 ± 5.94 SD) from the outpatient department of Rheumatology, University “Campus Bio-Medico, Rome, Italy, matched for age, sex, ethnicity and cardiovascular risk factors. A duplex Doppler sonographic study of carotids was performed in order to evaluate intima-media thickness (IMT), stiffness and haemodynamic parameters [resistivity and pulsatility indices (RI and PI, respectively)]. No significant difference was found between primary Sjögren syndrome and control patients in IMT, stiffness and haemodynamic parameters. The lack of significant difference in subclinical atherosclerosis between elderly primary Sjögren syndrome and control matched patients, indicates that traditional cardiovascular risk factors, immunologic alterations and chronic inflammation do not influence the progression of vascular damage in the carotid circulation of patients with median disease duration of 6.5 years.

Entities:  

Mesh:

Year:  2014        PMID: 25572746     DOI: 10.1177/039463201402700422

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  8 in total

1.  Metabolic syndrome in Sjögren's syndrome patients: a relevant concern for clinical monitoring.

Authors:  Kristopherson Lustosa Augusto; Eloisa Bonfa; Rosa Maria Rodrigues Pereira; Cleonice Bueno; Elaine Pires Leon; Vilma Santos Trindade Viana; Sandra Gofinet Pasoto
Journal:  Clin Rheumatol       Date:  2015-09-14       Impact factor: 2.980

2.  Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome.

Authors:  Cem Ozisler; Hatice Kaplanoglu
Journal:  Clin Rheumatol       Date:  2018-10-17       Impact factor: 2.980

3.  Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls.

Authors:  Enrico Maria Zardi; Maria Elena Pipita; Chiara Giorgi; Domenico Lichinchi; Domenico Maria Zardi; Antonella Afeltra
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

4.  Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in primary Sjögren syndrome.

Authors:  Selcan Gültuna; Sevinç Can Sandıkçı; Hatice Kaplanoğlu; Fevzi Nuri Aydın; Funda Seher Özalp Ateş
Journal:  Arch Rheumatol       Date:  2021-10-16       Impact factor: 1.007

5.  Cardiovascular Risk and Endothelial Dysfunction in Primary Sjogren Syndrome Is Related to the Disease Activity.

Authors:  Anna Łuczak; Rafał Małecki; Michał Kulus; Marta Madej; Ewa Szahidewicz-Krupska; Adrian Doroszko
Journal:  Nutrients       Date:  2021-06-17       Impact factor: 5.717

Review 6.  Atherosclerosis: a chronic inflammatory disease mediated by mast cells.

Authors:  Pio Conti; Yazdami Shaik-Dasthagirisaeb
Journal:  Cent Eur J Immunol       Date:  2015-10-15       Impact factor: 2.085

Review 7.  Causes of changes in carotid intima-media thickness: a literature review.

Authors:  Baoge Qu; Tao Qu
Journal:  Cardiovasc Ultrasound       Date:  2015-12-15       Impact factor: 2.062

8.  Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study.

Authors:  Xue-Fen Wu; Jing-Yang Huang; Jeng-Yuan Chiou; Huang-Hsi Chen; James Cheng-Chung Wei; Ling-Li Dong
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.